http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5240d95b992dbd18f2bf638001287dd
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Sharma |
| name | Sharad Sharma |
| given-name | Sharad |
| organization-name | Drug Safety Assessment, Novel Drug Discovery & Development, Lupin Limited (Research Park), Taluka-Mulshi, Pune, India Toxicology and Experimental Medicine Division, CSIR-Central Drug Research Institute, Lucknow, India Authors' Affiliations: 1Cancer Biology Research Center, Departments of 2Biomedical Sciences and 3Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas; 4Department of Neurosurgery, 5State Key Laboratory for Diagnosis and Treatment of Infectious Diseases at First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang; and 6Department of Life Science, Huaihua University, Huaihua, Hunan, PR China; Authors' Affiliations: 1Cancer Biology Research Center, Departments of 2Biomedical Sciences and 3Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas; 4Department of Neurosurgery, 5State Key Laboratory for Diagnosis and Treatment of Infectious Diseases at First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang; and 6Department of Life Science, Huaihua University, Huaihua, Hunan, PR China 2MacroGenics, Inc., Rockville, Maryland. Division of Toxicology and Experimental Medicine, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, India Ballarat Regional Integrated Cancer Centre, Grampians Health, Ballarat, Victoria, Australia Toxicology Division, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh 226031, India Drug Safety Assessment, Novel Drug Discovery and Development; Lupin Limited (Research Park); 46A/47A, Nande Village, MulshiTaluka Pune 412 115 India Contribution from the Department of Chemistry & Biochemistry and Department of Electrical Engineering, University of Notre Dame, Notre Dame, Indiana 46556-5670 Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India Division of Toxicology, CSIR-CDRI, Lucknow, Uttar Pradesh, India Department of Electronics and Communication Engineering, Maharishi Markandeshwar (Deemed to be University), Mullana, India. Ballarat Regional Integrated Cancer Centre Grampians Health Ballarat Victoria Australia Department of Pharmaceutical Sciences, 455 Kapoor Hall, School of Pharmacy & Pharmaceutical Sciences, The State University of New York at Buffalo, Buffalo, NY 14214, USA Authors' Affiliations: 1Department of Biomedical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas; 2Department of Life Sciences, Huaihua University, Huaihua, Hunan; P. R. China; 3Department of Neurosurgery and 4State Key Laboratory for Diagnosis & Treatment of Infectious Diseases, First Affiliated Hospital at Zhejiang University School of Medicine, Hangzhou, Zhejiang, P. R. China; 5Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas Nazih Zuhdi Transplant Institute, 3300 North West Expressway, Oklahoma 73112, USA. Novel Drug Discovery and Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47A, Village Nande, Taluka Mulshi, Pune 412115, India Department of Oncology Launceston General Hospital Launceston Tasmania Australia Academy of Scientific and Innovative Research , New Delhi , India; Toxicology Division, Council of Scientific and Industrial Research–Central Drug Research Institute , Lucknow , India CSIR-Central Drug Research Institute, Lucknow 226031, India |
Incoming Links
Total number of triples: 125.